首页> 外文期刊>Nature >Senescence surveillance of pre- malignant hepatocytes limits liver cancer development
【24h】

Senescence surveillance of pre- malignant hepatocytes limits liver cancer development

机译:恶性前肝细胞的衰老监测限制了肝癌的发展

获取原文
获取原文并翻译 | 示例
       

摘要

致癌基因诱导的衰老曾被发现起一个内在肿瘤rn抑制机制的作用.现在,Lars Zerlder及其同事rn提出了"衰老监测"的概念:他们发现,恶变rn前的衰老肝细胞能通过一个由肿瘤抗原引导的rn免疫反应被清除.这个过程需要CD4+T细胞的rn参与,并且在小鼠模型中抑制肝癌的发展.本rn文作者们还提供了这样的证据.衰老肝细胞会rn在免疫系统被抑制的患者肝脏中积累,说明衰rn老监测对人类也可能行得通.设计用来利用对rn恶变前的衰老细胞进行抗原特异性免疫监测的rn策略在癌症预防和治疗中可能会有潜力,而这rn种类型的抗原特异性免疫反应在疫苗生产中也rn可能会有用.%Upon the aberrant activation of oncogenes, normal cells can enter the cellular senescence program, a state of stable cell-cycle arrest, which represents an important barrier against tumour development in vivo1. Senescent cells communicate with their environment by secreting various cytokines and growth factors, and it was reported that this 'secretory phenotype' can have pro- as well as anti-tumorigenic effects2 5. Here we show that oncogene-induced senescence occurs in otherwise normal murine hepatocytes in vivo. Pre-malignant senescent hepatocytes secrete chemo- and cytokines and are subject to immune-mediated clearance (designated as 'senescence surveillance'), which depends on an intact CD4~+ T-cell-mediated adaptive immune response. Impaired immune surveillance of pre-malignant senescent hepatocytes results in the development of murine hepatocellular carcinomas (HCCs), thus showing that senescence surveillance is important for tumour suppression in vivo. In accordance with these observations, ras-specific Thl lymphocytes could be detected in mice, in which oncogene-induced senescence had been triggered by hepatic expression of Nras~(G12V). We also found that CD4~+ T cells require monocytes/ macrophages to execute the clearance of senescent hepatocytes. Our study indicates that senescence surveillance represents an important extrinsic component of the senescence anti-tumour barrier, and illustrates how the cellular senescence program is involved in tumour immune surveillance by mounting specific immune responses against antigens expressed in pre-malignant senescent cells.
机译:致癌基因诱导的衰老曾被发现起一个内在肿瘤rn抑制机制的作用.现在,Lars Zerlder及其同事rn提出了"衰老监测"的概念:他们发现,恶变rn前的衰老肝细胞能通过一个由肿瘤抗原引导的rn免疫反应被清除.这个过程需要CD4+T细胞的rn参与,并且在小鼠模型中抑制肝癌的发展.本rn文作者们还提供了这样的证据.衰老肝细胞会rn在免疫系统被抑制的患者肝脏中积累,说明衰rn老监测对人类也可能行得通.设计用来利用对rn恶变前的衰老细胞进行抗原特异性免疫监测的rn策略在癌症预防和治疗中可能会有潜力,而这rn种类型的抗原特异性免疫反应在疫苗生产中也rn可能会有用.%Upon the aberrant activation of oncogenes, normal cells can enter the cellular senescence program, a state of stable cell-cycle arrest, which represents an important barrier against tumour development in vivo1. Senescent cells communicate with their environment by secreting various cytokines and growth factors, and it was reported that this 'secretory phenotype' can have pro- as well as anti-tumorigenic effects2 5. Here we show that oncogene-induced senescence occurs in otherwise normal murine hepatocytes in vivo. Pre-malignant senescent hepatocytes secrete chemo- and cytokines and are subject to immune-mediated clearance (designated as 'senescence surveillance'), which depends on an intact CD4~+ T-cell-mediated adaptive immune response. Impaired immune surveillance of pre-malignant senescent hepatocytes results in the development of murine hepatocellular carcinomas (HCCs), thus showing that senescence surveillance is important for tumour suppression in vivo. In accordance with these observations, ras-specific Thl lymphocytes could be detected in mice, in which oncogene-induced senescence had been triggered by hepatic expression of Nras~(G12V). We also found that CD4~+ T cells require monocytes/ macrophages to execute the clearance of senescent hepatocytes. Our study indicates that senescence surveillance represents an important extrinsic component of the senescence anti-tumour barrier, and illustrates how the cellular senescence program is involved in tumour immune surveillance by mounting specific immune responses against antigens expressed in pre-malignant senescent cells.

著录项

  • 来源
    《Nature》 |2011年第7374期|p.547-551A2|共6页
  • 作者单位

    Helmholtz Centre for Infection Resea rch,lnhoffenstrasse 7,38124 Braunschweig, Germany;

    Helmholtz Centre for Infection Resea rch,lnhoffenstrasse 7,38124 Braunschweig, Germany,Hannover Medical School, Dept. ot Gastroenterology, Hepatology and Endocrinology, Carl-Neuberg-Strasse 1,30625 Hannover, Germany;

    Hannover Medical School, Dept. ot Gastroenterology, Hepatology and Endocrinology, Carl-Neuberg-Strasse 1,30625 Hannover, Germany;

    Helmholtz Centre for Infection Resea rch,lnhoffenstrasse 7,38124 Braunschweig, Germany;

    Helmholtz Centre for Infection Resea rch,lnhoffenstrasse 7,38124 Braunschweig, Germany,Hannover Medical School, Dept. ot Gastroenterology, Hepatology and Endocrinology, Carl-Neuberg-Strasse 1,30625 Hannover, Germany;

    Helmholtz Centre for Infection Resea rch,lnhoffenstrasse 7,38124 Braunschweig, Germany;

    Helmholtz Centre for Infection Resea rch,lnhoffenstrasse 7,38124 Braunschweig, Germany,Hannover Medical School, Dept. ot Gastroenterology, Hepatology and Endocrinology, Carl-Neuberg-Strasse 1,30625 Hannover, Germany;

    Helmholtz Centre for Infection Resea rch,lnhoffenstrasse 7,38124 Braunschweig, Germany;

    Helmholtz Centre for Infection Resea rch,lnhoffenstrasse 7,38124 Braunschweig, Germany;

    Helmholtz Centre for Infection Resea rch,lnhoffenstrasse 7,38124 Braunschweig, Germany;

    Twincore Centre for Experimental and Clinical Infection Research, Feodor-Lynen Strasse 7,30625 Hannover, Germany;

    Department of Internal Medicine III, University Hospital Aachen, 52074 Aachen, Germany;

    Helmholtz Centre for Infection Resea rch,lnhoffenstrasse 7,38124 Braunschweig, Germany;

    Department of Pathology, University Hospital Zurich, CH 8091 Zurich, Switzerland,Institute of Virology, Helmholtz Centre Munich, Technical University Munich, 81675 Munich, Germany;

    MRC Clinical Sciences Centre, Faculty of Medicine, Imperial College, Hammersmith Campus, London W12 ONN, UK;

    MRC Clinical Sciences Centre, Faculty of Medicine, Imperial College, Hammersmith Campus, London W12 ONN, UK;

    Helmholtz Centre for Infection Resea rch,lnhoffenstrasse 7,38124 Braunschweig, Germany;

    Hannover Medical School, Dept. ot Gastroenterology, Hepatology and Endocrinology, Carl-Neuberg-Strasse 1,30625 Hannover, Germany;

    University of Heidelberg, Institute of Pathology, Im Neuenheimer Feld 220/21, 69120 Heidelberg, Germany;

    Department of Internal Medicine III, University Hospital Aachen, 52074 Aachen, Germany;

    Twincore Centre for Experimental and Clinical Infection Research, Feodor-Lynen Strasse 7,30625 Hannover, Germany;

    Department of Internal Medicine III, University Hospital Aachen, 52074 Aachen, Germany;

    University of Heidelberg, Institute of Pathology, Im Neuenheimer Feld 220/21, 69120 Heidelberg, Germany;

    Clinic for Internal Medicine, District Hospital Reutlingen, Steinenbergstrasse 31, 72764 Reutlingen, Germany;

    Helmholtz Centre for Infection Resea rch,lnhoffenstrasse 7,38124 Braunschweig, Germany,Hannover Medical School, Dept. ot Gastroenterology, Hepatology and Endocrinology, Carl-Neuberg-Strasse 1,30625 Hannover, Germany;

  • 收录信息 美国《科学引文索引》(SCI);美国《工程索引》(EI);美国《生物学医学文摘》(MEDLINE);美国《化学文摘》(CA);
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

  • 入库时间 2022-08-18 02:54:50

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号